Abstract: The pathergy phenomenon (PP) is one of the hallmarks of Behcet's Disease (BD). It has been reported to be positive from 17.5% to 83% of cases in different studies. PP is used as a diagnosis criterion in the Dilsen criteria, the Japan criteria, the International criteria, and the Iran criteria. It is therefore important to know wether PP is a fix manifestation of the disease or a cyclic manifestation ...
Longitudinal study of the Pathergy phenomenon in Behcet’s Disease (BD).
Abstract: INTRODUCTION: The pathergy phenomenon (PP) is one of the hallmarks of Behcet's Disease (BD). It has been reported to be positive from 17.5% to 83% of cases in different studies. PP is used as a diagnosis criterion in the Dilsen criteria, the Japan criteria, the International criteria, and the Iran criteria. It is therefore important to know whether PP is a fix manifestation of the disease or a cyclic manifestation ...
Treatment of Ophthalmologic Manifestations Of Behcet’s Disease Comparison Of 6 Methods.
Abstract: Introduction: Opthalmologic manifestations are the major cause of morbidity in Behcet’s Disease. If not treated, they usually progress toward sever loss of vision or blindness. Cytotoxic drugs are the main therapeutic agents. Materials & Methods: In an open, non randomized, control study, pulse cyclophosphamide (PCP), low dose pulse cyclophosphamide (LDP), weakly methtrexate (MTX), chlorambucil (CHL), oral cyclophosphamide (OCP), and cyclosporine A (CYA) were used in a standard protocol for 778 patients. ...
Behcet’s Disease. Analysis of 2806 cases.
Abstract: There are only two nationwide surveys of Behcet's Disease (BD) in the world, one from Japan and one from Iran. The comparison of the two surveys is interesting because the populations are racially different, although they share same genetic background via the invasion of Iran by Turk tribes (from the northem part of China) in the 10 th and 13 th century. The annual incidence of BD in Iran is 350 ...
Study of Bone Mineral Density (BMD) in 1335 patients with non inflammatory diseases.
Abstract: In order to study a possible relation between mechanical bone pains and the BMD, 1335 patients were analyzed as every consecutive patient. The BMD was measured in a cohort study on 5927 patients referred for various reasons to the Rheumatology Research Center, Osteoporosis Unit. The BMD was measured by Dual Energy X-rays Absorptiometry (DEXA) on the lumbar spine (L1-L4) and the femoral neck. Patients having an inflammatory disease such as ...
Natrium Fluoride for the Treatment of Osteoporosis in Rheumatoid Arthritis Patients.
Abstract: In Rheumatoid Arthritis (RA) osteoporosis is secondary. Its cause and its treatment are still controversial. All agents used in post menopausal osteoporosis have been tried for RA osteoporosis. Our work is a prospective open study to demonstrate the efficacy of low dose NF (20 mg daily) in these patients. Sixty two patients with RA and osteoporosis (t score less than 2.5 standard deviation, as defined by WHO) entered the study. BMD ...
Treatment of Osteoporosis by Natrium Fluoride.
Abstract: Natrium Fluoride (NF) is one of the best treatments of osteoporosis because it is cheap, it has no major side effects, and it is effective (Heany et al., Farley et al., Dure-Smith et al., Kanis et al., and Pak et al.). Our work is a prospective open study to demonstrate the efficacy of low dose NF (20 mg daily) in post menopausal osteoporosis. Fifty six patients with osteoporosis (t score less ...
Evaluation and Risk Factors in the Ocular Behcet’s Disease.
Abstract: Porpose: To determine the risk factors in the prognosis and the visual outcome of the disease. Methods: This is a retrospective study of 361 patients, having Behcet’s disease and treated by immunosuppressives and steroids, followed-up at Shariatti Hospital (mean duration of follow-up was 2.27 years). The ocular examinations at the first and last visit are recorded and compared. Results: Vision ...
Long-Term Follow up of Type IV SLE Nephritis (without renal failure) Treated by Pulse Cyclophosphamide.
Abstract: Results of PCP are well known in lupus nephritis. We present here it’s outcome in patients with WHO type IV lupus nephritis, treated before the occurrence of renal failure. Patients having a follow up of more than 36 months were selected for this study. 29 patients fulfilled the selection criteria. Proteinuria, hematuria, leucocyturia, cast, BUN, creatinine and blood pressure were measured before PCP and after each one. The first and ...
Relationship of pathergy phenomenon and Behcet's disease (BD) manifestations.
Abstract: In a study on 391 cases of BD presented to the EULAR Congress in 1987 we demonstrated that the following symptoms were seen more frequently in patients with positive pathergy phenomenon: oral aphthosis as the initial manifestation of the disease, genital ulcerations, pseudofolliculitis, and arthralgia. The following symptoms, on the contrary were seen less frequently: oral aphthosis, ankylosing spondylitis. It was interesting to look after those findings, 6 years later, in ...